Funr (FUNR) Stock Price & Analysis
FUNR — price $1.00 (+376.19%), as of the Oct 2, 2026 trading session; market cap $10.0B.
Educational signal · not a buy or sell recommendation · How to read this
Funr · FUNR · Technology · Communication Equipment
Research dated 2026-09-13: FUNR trades on the OTC market as the shell of International Precious Metals Corp, renamed from Cuba Beverage Company with stated focus on BioTech, MedTech, and artificial intelligence intellectual property licensing. The central question is whether this rebrand reflects actual development or remains a dormant corporate vehicle.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $1.00 |
| Change on the day | +376.19% |
| 52-week range | $0.0001–$20000.00 |
| Market capitalisation | $10.0B |
| Shares traded on the day | 107 |
| Beta (volatility vs the S&P 500) | -1.83 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Funr (FUNR): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the FUNR film — every key number, told as a short cinematic story
~2 min · open the film
What is Funr (FUNR), and what does it report?
Short answer · as of
The company claims to focus on BioTech, MedTech, Statistical Data Gathering, and artificial intelligence combined with intellectual property and brand licensing across multiple FUNR divisions.
Research dated 2026-09-13.
The company claims to focus on BioTech, MedTech, Statistical Data Gathering, and artificial intelligence combined with intellectual property and brand licensing across multiple FUNR divisions. The reporting structure reveals almost no sales activity. A filing gap spanning decades makes it impossible to confirm whether the renamed entity conducts actual research, development, or commercialization.
What do the latest results show for Funr (FUNR)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of $6,220.
Research dated 2026-09-13.
The most recent quarterly results show revenue at minimal levels with consistent operating losses. Cash and short-term investments record as absent across all reported periods. The company carries minimal debt, suggesting neither meaningful cash generation nor significant creditor obligations, only ongoing quarterly depletion from operating expenses.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $0.00 Jun 30, 2026
- Latest quarter · SG&A
- $24,000 Jun 30, 2026
- Latest quarter · FMP standardized operating result
- −$24,000 Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $0.00 | Not available | $24,000 | −$24,000 |
| Mar 31, 2026 | $0.00 | Not available | $32,000 | −$32,000 |
| Dec 31, 2025 | $6,000 | Not available | $26,000 | −$19,000 |
| Sep 30, 2025 | $0.00 | Not available | $30,000 | −$30,000 |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Quarterly income statement — 1 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | $6,220 | $21,219 | $0.00 (diluted) |
What are the financial strengths and risks for Funr (FUNR)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2025 balance-sheet date. Operating cash flow was −$30,000 for the quarter ended Jun 30, 2026, meaning operations used cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
The absence of material debt means the company faces no immediate solvency pressure from creditors. Conversely, the lack of liquid resources combined with consistent quarterly losses implies the shell is consuming its remaining capital structure. The fundamental risk is that a dormant vehicle with aspirational business claims but no SEC filings may never transition to legitimate operations, leaving shareholders with a trading shell backed by no substantive business.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- −$30,000 Jun 30, 2026
- Previous quarter · operating cash flow
- −$10,000 Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | −$30,000 | Not available |
| Mar 31, 2026 | −$10,000 | Not available |
| Dec 31, 2025 | −$160,000 | Not available |
| Sep 30, 2025 | −$30,000 | Not available |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at Funr (FUNR)?
Research dated 2026-09-13.
The critical diagnostic is whether the company files material periodic updates in coming periods. A resumption of SEC filings detailing actual BioTech or MedTech research, product development, or partnership agreements would signal genuine operational change. Until then, the filing gap remains the clearest indicator that the corporate rebrand reflects aspiration rather than execution.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How is Funr scored?
Research dated 2026-09-13.
Meaningful comparison to operating BioTech or MedTech enterprises is not possible, as FUNR shows no revenue, no disclosed product development, no analyst coverage, and no scoring methodology application. It is functionally a dormant shell with an aspirational rebrand, not a development-stage competitor in biotech or medical technology. The absence of analyst interest and the quality gate assessment reflect the company's lack of substantive business signals.
| Company | Price | Market value | Score |
|---|---|---|---|
| $1.00 Oct 2, 2026 | — | — Model unavailable | |
| $0.20 Oct 2, 2026 | $5.92M | — Model unavailable | |
| $112.20 Oct 2, 2026 | $442B | — 5-pillar · not comparable | |
| $69.35 Oct 2, 2026 | $91.8B | — 5-pillar · not comparable | |
| $1085.42 Oct 2, 2026 | $84.5B | — 5-pillar · not comparable | |
| $447.41 Oct 2, 2026 | $74.3B | — 5-pillar · not comparable | |
| $10.60 Oct 2, 2026 | $57.3B | — 5-pillar · not comparable | |
| $391.34 Oct 2, 2026 | $55.4B | — 5-pillar · not comparable | |
| $218.64 Oct 2, 2026 | $40.8B | — 5-pillar · not comparable | |
| $620.52 Oct 2, 2026 | $37.6B | — 5-pillar · not comparable | |
| $9.29 Oct 2, 2026 | $30.5B | — 5-pillar · not comparable | |
| $58.45 Oct 2, 2026 | $23.8B | — 5-pillar · not comparable |
The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
What Investors Ask About Funr (FUNR) — Technology
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
Has FUNR filed any substantive disclosure since the rebrand?
No SEC filings appear in the company's feed after the rebranding. The gap from earlier decades through to the present remains unbroken by any periodic disclosure of development activity or business operations.
Does FUNR hold any cash or liquid resources?
The company reports no cash or short-term investments across all periods in the filing record. Quarterly operating losses suggest ongoing consumption of whatever capital structure the entity maintains, leaving it with minimal ability to fund new initiatives.
Who is the chief officer of FUNR?
Alex Procopio serves as Chairman and Chief Executive Officer. Beyond the named title, no public compensation data, biographical detail, or insider transaction history appears in available records.
What would confirm FUNR is developing the BioTech business it describes?
A resumption of SEC periodic filings with substantive product descriptions, development milestones, partnership agreements, or patent activity would be the primary signal of real progress. The absence of filings is the clearest indication that the stated business claims remain unrealized.
What is the FUNR stock price today?
The last price recorded on this page for FUNR is $1.00, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (30 figures)
The 30 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates are shown with the basis each row actually carries; capture and recorded dates are not relabelled as provider-effective dates, and derived figures restate their arithmetic. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 1 fact from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
id.hq | SEC filing business address | Phoenix, AZ | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "4901 Morena Boulevard, San Diego, CA, 92117, US". |
FMP — 29 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $1.00 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T00:34:42.752Z. | |
px.change | Change on the day | +376.19% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalization | $10.0B | FMP | Financial Modeling Prep (FMP) quote — Provider market cap uses the share class it prices; a company with more than one class may show a larger total elsewhere. Market cap record date: 2026-10-02. Source capture time was not supplied. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$0.79 | FMP | Financial Modeling Prep (FMP) · quote | |
px.range52 | 52-week range | $0.0001–$20000.00 | FMP | Financial Modeling Prep (FMP) quote | |
px.volume | Shares traded on the day | 107 | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | -1.83 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Alex Procopio | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
fin.q_revenue | Revenue, Q4 FY2025 | $6,220 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $0.00, net result −$70,000; FY2022 revenue $0.00, net result −$180,000; FY2023 revenue $0.00, net result −$100,000; FY2024 revenue $10,000, net result −$40,000; FY2025 revenue $10,000, net result $210,000 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $24,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | −$24,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $32,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | −$32,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $6,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $26,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | −$19,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $30,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | −$30,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table | Quarterly income statement | 1 quarters through Q4 FY2025 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $0.00 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. The market-value ratio is undefined when the reported amount is zero. | |
fin.opcf_latest | Latest-quarter operating cash flow | −$30,000 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | −$30,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | −$10,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | −$160,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | −$30,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Ticker / exchange | FUNR on Other OTC | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Legal name | INTERNATIONAL PRECIOUS METALS CORP Our market-data provider lists the name as "Funr"; the filer's own record is used here. | 1998-03-31 | OFFICIAL | SEC EDGAR — 10-K filed 1998-03-31 |
| Business description | FUNR is focused on the development of proprietary BioTech, MedTech, Statistical Data Gathering combined with AI technology. The Company concentrates on intellectual property/brand licensing with the goal of several divisions under the FUNR community and umbrella. The company was formerly known as Cuba Beverage Company and changed its name to FUNR in October 2022. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Listed since | 1994-10-31 | 1994-10-31 | FMP | Financial Modeling Prep (FMP) company profile |
| Most recent periodic reports | Annual: Filed: 1998-03-31, Period end: 1997-12-31; Quarterly: Filed: 1998-05-20, Period end: 1998-03-31 | 1998-05-20 | OFFICIAL | SEC EDGAR filer submissions |
| What the sources do not tell us | Captured record · 9 entries
Each entry names a family of information the packet has no fact for.; The list is drawn from a fixed catalogue keyed to fact ids — it is not written per ticker and contains no generated text.; An absent family means our sources did not answer; it does not mean the company has nothing to report. | 2026-09-13 | COMPUTED | Derived from which sources answered this build |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2025-09-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash, investments and debt | Total debt: $30,000; Liquidity basis: cash and short-term investments; Total liabilities: $50,000; Cash and short-term investments: $0; Cash and investments: $0; Long-term investments: $0; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2025-09-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $0; Cash and short-term investments: $0; Long-term investments: $0; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2025-09-30 | COMPUTED | Computed from the balance sheet |
| Trailing twelve-month ratio set | Quick ratio: 0; Current ratio: 0; Debt to equity: -87.9; Net margin: -2,701.8%; Operating margin: -1,686.6%; Return on assets: -314.1% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Cash against market value | As of: 2025-09-30; Cash basis: cash and short-term investments; Net cash: $0; Total debt: $0; Cash and investments: $0 Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2025-09-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Page quality gate score | 26 How much source material this page has to work with — not a view on the stock. | 2026-09-13 | OURS | Stock Expert AI quality gate (0-100) |
| Named officers | CEO: Alex Procopio; Officers: Alex C. Procopio — Title: Chairman & Chief Executive Officer Titles and pay come from the company's proxy statement as our provider parsed it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) |
Data provided for informational purposes only.